Not currently recruiting at UCSD
A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation
Summary
- Eligibility
- for people ages 40 years and up (full criteria)
- Location
- at San Diego, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Carolyn Mulroney, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSD
- Carolyn Mulroney, MD
Co-Investigator on several clinical trials in the Blood and Marrow Transplantation Division: BMTCTN 0402, IRB # 101006, A Phase III Randomized, Multicenter Trial comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as a Graft-Versus-Host Disease (GVHD) Prophylaxis After HLA- Matched, Related Peripheral Blood Stem Cell transplantation. B.A.
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Angiocrine Bioscience
- ID
- NCT05181540
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 148 study participants
- Last Updated